Lipocine (LPCN) Institutional Ownership $2.89 -0.01 (-0.34%) Closing price 03:59 PM EasternExtended Trading$2.90 +0.01 (+0.35%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$15.85KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.98K Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673% 2/12/2025 Geode Capital Management LLC57,464$280K0.0%+6.0%1.074% 8/9/2024 Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480% 8/9/2024 Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222% 1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023 EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022 Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021 Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021 Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021 State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021 Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on Lipocine's institutional investors. What percentage of Lipocine's stock is owned by institutional investors? 9.11% of Lipocine's stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine's stock? The following institutional investors have purchased Lipocine's stock in the last 24 months: Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 3,248 shares in the last 24 months. This purchase volume represents approximately $15.85K in transactions. Which of Lipocine's major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Renaissance Technologies LLC ($4.30K). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 4,300 shares in the last 24 months. This volume of shares sold represents approximately $20.98K in transactions. Related Companies ALXO Major Shareholders KPTI Major Shareholders IZTC Major Shareholders CUE Major Shareholders HOWL Major Shareholders DRRX Major Shareholders ICCC Major Shareholders PDSB Major Shareholders DTIL Major Shareholders ATNM Major Shareholders This page (NASDAQ:LPCN) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
